在创伤重症监护室新升级的精神药物:在护理过渡期间处方模式
Jennifer Spadgenske1, Heather Rhodes2, Rachel Nelson2
1Sanford Medical Center, Fargo, ND, USA.
The Annals of pharmacotherapy
|November 14, 2025
概括
心理药物治疗升级在重症创伤患者中很常见. 许多患者在ICU转移和出院后继续服用这些药物,强调需要更好的护理过渡管理.
科学领域:
- 关键护理医学 关键护理医学
- 创伤外科 手术 创伤外科
- 心理药理学 心理药理学
背景情况:
- 在混合ICU人群中,抗精神病药物的持续率各不相同 (21-61%).
- 手术ICU入院是危险因素,但创伤数据有限.
研究的目的:
- 在重症创伤患者中评估心理药物升级.
- 确定在ICU转移和医院出院时的延续率.
主要方法:
- 在手术ICU中对成年创伤患者的回顾性研究 (2021年12月 - 2023年5月).
- 定义升级为新的或增加的精神药物剂量.
- 评估妄想/兴奋作为升级的迹象.
主要成果:
- 51.4%的患者在ICU中升级了精神药物治疗.
- 35%和31.8%的人在ICU转移和出院时继续服用药物.
- 出院目的地有所不同:55.6%是康复中心,28.9%是家庭中心,13.3%是长期护理中心.
结论:
- 在手术ICU创伤患者中,精神药物升级是常见的.
- 需要进一步研究在护理过渡期间的精神药物处方.
更多相关视频
09:55Use of a Psychophysiological Script-driven Imagery Experiment to Study Trauma-related Dissociation in Borderline Personality Disorder
Published on: March 8, 2018
13.1K
08:13Development and Implementation of a Multi-Disciplinary Technology Enhanced Care Pathway for Youth and Adults with Concussion
Published on: January 20, 2019
7.0K
相关概念视频
Drug Therapy
236
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
236
Psychosis: Goals of Pharmacotherapy
453
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
453
Psychosis and Antipsychotic Drugs: Overview
788
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
788
Drug Dosing: Geriatric Patients
215
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
215
Acute Coronary Syndrome IV: Interprofessional Care
205
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
205
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189
